Aimei Health Technology Co., Ltd (AFJK)

Aimei Health Technology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023
Period Ending	Sep 30, 2024	Dec 31, 2023
Net Income	2.37	0.26
Other Operating Activities	-3.07	-0.29
Change in Other Net Operating Assets	0.22	0.04
Other Investing Activities	-104.54	-104.54
Investing Cash Flow	-104.54	-104.54
Total Debt Issued	0.31	0.31
Total Debt Repaid	-0.32	-0.32
Net Debt Issued (Repaid)	-0.01	-0.01
Issuance of Common Stock	108.49	108.52
Other Financing Activities	-3.09	-3.11
Financing Cash Flow	105.4	105.41
Net Cash Flow	0.38	0.87

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q